Georgy Artemyevich Galegov

Georgy Artemyevich Galegov (born on December 29, 1931, Moscow), Virologist, Doctor of Biological Sciences (1971), Professor (1976), Award of the Council of Ministers of the USSR (1985), Order of the Red Banner of Labor (1984), National Award of the Russian Federation (2000).

In 1950, entered the First Moscow Medical Institute (Department of General Medicine) to graduate from it in 1956. He worked in the Institute of Biological and Medical Chemistry of the Academy of Medical Sciences of the USSR from 1956 to 1963. Since 1963, he has been working in D.I. Ivanovsky Institute of Virology of the Russian Academy of Medical Sciences as a senior researcher, since 1965 – as the head of the Viral Infection Chemical Therapy Laboratory. In 1999 through 2012, he was also the head of the General Virology Department. In 1996 through 2012, he was a professor at the Chair of Virology of I.M. Sechenov First Medical University.

His teachers in science were members of the Academy of Medical Sciences S.R. Mardashev, S.S. Debov, and V.M. Zhdanov. Research activities of Georgy Galegov are related to setting up and development of the problem of chemical therapy of viral infections in the country and development of medicines for drug therapy of viral infections. He and his staff, working in cooperation with member of the Academy of Medical Sciences V.I. Votyakov, developed and introduced modern methods for assessment of antivirus drugs' action in the influenza, arbovirus, herpes virus, and HIV/AIDS models. Galegov's studies in virus enzymology, exploration of modified nucleosides' and adamantane derivatives' antiviral action, combined chemical therapy of viral infections and development of the system to affect virus variants with drug resistance achieved prominence and recognition. Galegov made a certain contribution to development and introduction of Remantadin (anti-flue drug), development and introduction of the Russian variant of Ribavirin and creation of Nikavir – the new anti-HIV/AIDS drug. He has set up a school of virologists specializing in chemical therapy and trained 24 candidates and doctors of sciences.

A cycle of studies by Galegov devoted to efficient impact of influenza and herpetic infections caused by virus variants with drug resistance and disclosing the mechanisms of such impact received significant prominence and recognition. Galegov is a member of the Specialized Scientific Council for Defense of Doctoral Theses in Virology, Epidemiology, and Infectious Diseases, a member of the Interindustry Council on Virology of the Academy of Medical Sciences of Russia, a member of the editorial staff of the Problems of Virology journal, a member of the team of authors publishing the annual Federal Guidance on Use of Drugs, from 1991 to 2008, he was a Chairman of the Task Team for Chemical Therapy and Chemical Prophylaxes of Viral Infections of the Russian Academy of Medical Sciences, for many years he was a virology expert of the Pharmacological Committee of the Ministry of Healthcare and Social Development of the Russian Federation. Galegov is an author and a co-author of 450 research paper published in the national and foreign print media.